Lifeline Scientific, Inc., a medical technology company, develops products and services for cell, tissue, and organ transplantation in the United States and internationally. It offers LifePort Kidney Transporter, a medical device that provides kidney preservation, evaluation, and transport prior to transplantation; and LifePort Liver Transporter, a device used in liver transplantation. The company also provides Vasosol, a machine perfusion solution; Universal SealRing Cannula, which allows the use of organs with limited vascular access; LifePort Kidney Transporter rolling Cover that provides protection and manoeuvrability for LifePort Kidney Transporter while in transit; and LifePort WorkStation, which accommodates a range of medical solutions and additive gases.

Signal Pharmaceuticals is a biopharmaceutical company that was founded by David Anderson (Senior VP & Head of Research), Alan Lewis (CEO), Mark Carmen, and Jackie Johnson and is based in California. It was acquired by Celgene in 2009

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Manufactures pharmaceuticals and diagnostic substances

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan.

CellResearch Corporation was founded in Singapore in 2002 by scientists with a keen interest and expertise in Cell Biology. It’s original remit was to provide skin and scar cells to laboratories around the world for research, as well as to perform contract research for cell laboratories internationally. In 2004, our scientists isolated Epithelial and Mesenchymal Stem Cells from the Umbilical Cord Lining Membrane. This novel and significant discovery was put up for intellectual property protection, and to date we have patents granted in multiple strategic key territories around the world. The umbilical cord lining membrane is now known to be the richest source of stem cells in the body, and both epithelial and mesenchymal stem cells are being researched intensively with collaborators all around the world to exploit their potential for downstream medical therapy. Considerable headway has already been achieved, and we are due shortly to start USFDA Clinical Trials with our collaborators in the USA, leading to a therapy to accelerate wound healing. To maximise future Cord Lining Stem Cell use, CellResearch Corporation feels that the membrane from which the cells are derived should be stored. Today we license our proprietary technology to partners who bank Cord Lining Membrane in various territories around the world. Our extensive experience with Cord Lining Stem Cells has taught us much, and we have been able to utilise this knowledge to produce a ground breaking cosmeceutical line called CALECIM® which has been observed to improve the skin appearance after topical application.

Shanghai Fengni Pharmaceutical Technology Co., Ltd., established on 2014-01-27, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;food sales(Only sell prepackaged food);Sales of Class I Medical Devices;Retailing of Edible Agricultural Products;Wholesale of edible agricultural products;Health Consulting Services(Does not include medical services);internet sales(Except for products that require a license for sale).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

NTG Nordic Transport Group A/S is an international forwarding and logistics provider for road freight, sea freight, air freight and contract logistics. It operates through two segments: Road & Logistics and Air & Ocean. The Road & Logistics segment provides transport and warehousing solutions with a geographical focus on Europe. The Air & Ocean segment provides international air and ocean freight services, including project transports. The company was founded by Jørgen Buus Lassen in 1989 and is headquartered in Hvidovre, Denmark.

Fidia SpA designs, produces and distributes integrated milling systems, which is applied in the manufacturing of molds and dies for automotive industry and in aerospace field. It also provide solutions for the complete milling process, from the definition of the machining program to the finished product. The company was founded by Giuseppe Morfino in 1974 and is headquartered in San Mauro Torinese, Italy.

Merz Pharma GmbH & Co. KGaA is an innovative and international healthcare company with its own research and development department. It focuses on drugs for the treatment of illness in the fields of neurology and psychiatry. The company is bundling the activities of its subsidiaries Merz Pharmaceuticals, Merz Consumer Care, Merz Dental, and Merz Hygiene, with products ranging from prescription drugs and OTC products for health and wellness, materials for dentists and dental technicians to hygienic products for medical disinfection and cleaning.\nThe units of Merz Group Services, the fith Merz subsidiary, include Human Resources, Supply Chain/Purchasing, Information Technology (IT), Technical Operations and Finances/Controlling.

Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.

Morinaga Milk Industry Co., Ltd. engages in the production and distribution of dairy products. Its operations are carried out through the following segments: Food Products and Others. The Food Products segment engages in the production and sale of milk, dairy-based beverages, yogurt, desserts, condensed milk, powdered milk, butter, cheese, ice cream, non-dairy beverages (juice, tea, coffee), and clinical liquid diets. The Others segment provides the real estate leasing services. It also engages in the manufacture and sale of animal feeds; design and construction of plant equipment. The company was founded on September 1, 1917 and is headquartered in Tokyo, Japan.

Acts as an alternative investment manager

Bayer Schering Pharma AG is a research-centered pharmaceutical company that was formed by the merger of Schering with Bayer on 29 December 2006. The company was originally founded in 1851 by Ernst Christian Friedrich Schering. The company employs more than 26,000 people in 140 subsidiaries all over the world. The company's headquarters are in Berlin-Wedding, Germany and the forerunner company Schering's annual gross revenue was nearly € 5 billion. They retain the largest German manufacturing facility which is located in Bergkamen. The company focuses on the business areas of gynaecology and andrology, oncology, and also special therapeutics, diagnostical devices, and nuclear medicine. Schering's best-known product is their line of combined oral contraceptive pills. Through Bayer Healthcare AG, Bayer Schering Pharma is a full member of the European Federation of Pharmaceutical Industries and Associations.

Hunchun Shenyi Fungus Biotechnology Development Co., Ltd., established on 2006-01-12, The business scope includes edible fungi,Research and development of strains;Mushroom Cultivation and Planting;Production of mushroom sticks,Sales and technical promotion;Mushroom processing;Agricultural product acquisition;Import and export trade permitted by laws and regulations.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Chengdu Master Mobile Information Technology Co., Ltd., established on 2008-07-17, Business scope includes computer software and hardware system development,Sales,consult;electronic product,communication equipment(Excluding radio broadcasting and television transmitting equipment and satellite ground receiving equipment),Software and hardware system development of electromechanical products,Sales;arts and crafts design;Market information consultation;Computer Network System Design,construction;Design of Security Technology Defense System,construction,repair(The above projects are engaged in operation with qualification license);computer system integration;Information service business in the second category of value-added telecommunications business(Excluding fixed-line telephone information service)(Internet information services excluding news,publishing,educate,medical insurance,medicine,Medical devices and electronic bulletin services, etc.)(Engage in business within the validity period with the value-added wire business license);Import and export,Technology Import and Export(National law,Except where prohibited by administrative regulations;law,Operations can only be carried out after obtaining a license restricted by administrative regulations).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).